- Home
- BXC vs HQL Comparison
BXC vs HQL Comparison
Compare BXC & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BXC | HQL |
|---|---|---|
| Founded | 2004 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 502.3M | 510.2M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | BXC | HQL |
|---|---|---|
| Price | $75.66 | $16.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $88.67 | N/A |
| AVG Volume (30 Days) | 94.5K | ★ 120.9K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.71 | 0.79 |
| Revenue | ★ $2,948,840,000.00 | N/A |
| Revenue This Year | $0.63 | N/A |
| Revenue Next Year | $3.06 | N/A |
| P/E Ratio | $42.00 | ★ $17.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $52.71 | $11.34 |
| 52 Week High | $114.19 | $14.37 |
Technical Indicators
Market Signals| Indicator | BXC | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 72.24 | 45.23 |
| Support Level | $60.76 | $16.15 |
| Resistance Level | $65.76 | $17.29 |
| Average True Range (ATR) | 3.03 | 0.35 |
| MACD | 1.27 | -0.03 |
| Stochastic Oscillator | 97.49 | 43.80 |
Price Performance
Historical ComparisonAbout BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.